Kremmyda, Olympia http://orcid.org/0000-0002-6663-4263
Frenzel, Claudia
Hüfner, Katharina
Goldschagg, Nicolina
Brem, Christian
Linn, Jennifer
Strupp, Michael
Funding for this research was provided by:
BMBF (01EO0901)
Article History
Received: 21 April 2020
Revised: 12 July 2020
Accepted: 14 July 2020
First Online: 14 August 2020
Compliance with ethical standards
:
: The authors report no conflict of interest.
: M. Strupp is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology and Section Editor of F1000. He has received speaker’s honoraria from Abbott, Actelion, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, Merck, MSD, Otometrics, Pierre-Fabre, TEVA, and UCB. He is a shareholder of IntraBio. He acts as a consultant for Abbott, Actelion, AurisMedical, Heel, IntraBio and Sensorion. He is the distributor of M glasses. O.Kremmyda, C. Frenzel, C. Brem, K. Hüfner, N. Goldschagg, and J. Linn report no disclosures.
: The study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of the LMU Medical Faculty (Study Number: 314-10).
: All patients signed a written informed consent form before participating in the study.